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Summary
Crohn’s disease (CD) is a complex and highly heterogeneous chronic
inflammatory disorder, primarily affecting the gastrointestinal tract.
Genetic and functional studies have highlighted a key role for innate
immunity in its pathogenesis. Profound systemic defects in innate immu-
nity and acute inflammation are understood to result in markedly delayed
clearance of bacteria from the tissues, leading to local chronic granuloma-
tous inflammation and compensatory adaptive immunological changes.
Macrophages, key orchestrators of acute inflammation, are likely to play
an important role in the initial impaired innate immune response. Mono-
cyte-derived macrophages from CD patients stimulated with Escherichia
coli were shown to release attenuated levels of tumour necrosis factor and
interferon-c with normal secretion of interleukin-8 (IL-8), IL-10 and IL-6.
In controls, the secretion of these cytokines was strongly positively corre-
lated, which was not seen with CD macrophages. The transcriptomes of
CD and control macrophages were examined in an attempt to understand
the molecular basis of this defect. There were no differentially expressed
genes identified between the two groups, consistent with genetic heteroge-
neity; however, a number of molecules were found to be under-expressed
in subgroups of CD patients. The most common of these was optineurin
(OPTN) which was under-expressed in approximately 10% of the CD
patients. Reduced OPTN expression coincided with lower intracellular
protein levels and diminished cytokine secretion after bacterial stimula-
tion both in the patients and with small interfering RNA knockdown in
THP-1 cells. Identifying and studying subgroups of patients with shared
defective gene expression could aid our understanding of the mechanisms
underlying highly heterogeneous diseases such as CD.
Keywords: cytokine; gene expression; inflammatory bowel disease; immu-
nodeficiency; inflammation.
Introduction
Crohn’s disease (CD) is a chronic inflammatory disorder,
primarily affecting the gastrointestinal tract. It arises
through an aberrant interaction between the bowel con-
tents and the immune system, although the mechanistic
basis of disease pathogenesis remains poorly understood.1
Family and twin studies demonstrate that the disease has
a strong genetic component; the disease concordance is
nearly 30% in monozygotic twins compared with 2% in
dizygotic twins.2 Characterization of the genetic basis of
CD has gathered pace in recent years through the use of
genome-wide association studies3 and subsequent meta-
analyses which, to date, have identified 140 loci associated
with CD.4 It has been estimated that these susceptibility
variants account for approximately 14% of the total dis-
ease variance.4 Although many of the associated loci are
suspected of influencing the immune system, the func-
tional variants within each locus and the underlying path-
ogenic mechanisms remain unclear.5 The most
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significantly enriched Gene Ontology category associated
with the 140 genome-wide association study loci was the
regulation of cytokine production, specifically tumour-
necrosis factor-a (TNF-a), interferon-c (IFN-c), interleu-
kin-12 (IL-12) and IL-10 signalling.4
It is becoming increasingly evident that most cases of
CD result from an innate immunodeficiency6 and a pri-
mary pathogenic defect has been shown in the monocyte-
derived macrophage (MDM) response to bacteria.7–9
Macrophages orchestrate cellular responses against a com-
plex and diverse range of intestinal microbial insults via
pattern recognition receptors such as Toll-like receptors
(TLR) and NOD-like receptors (NLR).10,11 Activation
through these receptors leads to the secretion of inflam-
matory mediators that recruit leucocytes from the sur-
rounding microcirculation. It has been postulated that
the dysregulated macrophage response to bacteria may be
central to the pathogenesis of CD12 and a number of
studies on monocytes/macrophages from CD patients
have reported reduced pro-inflammatory cytokine release,
in response to NLR, TLR and bacterial stimulation.7–9,13
CD-associated polymorphisms in NOD2 (L1007finsC,
R702W, G908R) result in impaired immunity, through
defective nuclear factor-jB activation and deficient
secretion of pro-inflammatory cytokines in response to
muramyl peptide (a component of bacterial peptidogly-
can).13,14 However, the majority of CD patients do not
carry these polymorphisms in NOD2 and respond nor-
mally to muramyl peptide.9,13 Attenuated secretion of
pro-inflammatory cytokines by macrophages is likely to
have a profound effect on the innate immune response
in these individuals. The previously reported impaired
neutrophil recruitment and delayed bacterial clearance
reported in patients with CD may well be secondary to
abnormal cytokine secretion.9,15,16 The retention of the
undigested bacteria at sites of ingress was proposed to be
the driving force for the ensuing chronic granulomatous
inflammation, and secondary adaptive immune response
characteristic of CD.12
Cytokine secretion is a highly complex and tightly reg-
ulated process.17 Different cell types have been shown to
possess unique activation and secretory pathways, and
furthermore, multiple exocytosis pathways have been
identified for individual cytokines.18 To understand the
defective macrophage secretory mechanisms associated
with CD we have concentrated our study on TNF-a, IFN-
c, IL-6, IL-8 and IL-10, which have been shown to be
abnormal in CD9,15,19 and used transcriptomic analyses in
an attempt to identify the responsible molecules.
Materials and methods
Ethics approval and patient recruitment
Adult patients with a definitive diagnosis of CD con-
firmed using standard diagnostic criteria were recruited
from the Gastroenterology outpatient clinic at University
College London Hospitals NHS Foundation Trust
(UCLH). All patients had quiescent disease (CD; Harvey–
Bradshaw Activity index ≤ 3).20 The demographics of
patients included in this study are outlined in Table 1.
These studies were approved by the Joint UCL/UCLH
Committees on the Ethics of Human Research (02/0324).
Written informed consent was obtained from all
Table 1. Patient demographics
HC CD
HC versus
CD P-value CDlow
CD versus
CDlow P-value
n= 42 58 7
Gender (M:F) 22 : 20 29 : 29 084 6 : 1 011
Mean age  SD 378  104 391  140 064 493  168 006
Age range 22–61 19–69 24–66
Current smokers 4 5 100 1 051
Treatment
No medication 17 2 100
5-Aminosalicylates 36 3 020
Immunosuppressants 8 2 059
Biological agents 2 0 100
Disease location
L1 15 1 067
L2 15 2 100
L3 27 4 100
L4 1 0 100
Perianal involvement 16 3 067
Crohn’s disease (CD) patients, healthy control (HC) volunteers and patients expressing low OPTN levels (OPTNlow); gender, age at sam-
pling  SD, smoking status, current medication and phenotypes (L1 ileal, L2 colonic, L3 ileocolonic, L4 oral) are shown.
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volunteers. No patient was studied more than once in
each of the different sets of experiments.
Monocyte-derived macrophage isolation
Peripheral venous blood samples were collected into hep-
arin (5 U/ml). Mononuclear cells were isolated by differ-
ential centrifugation (900 g, 30 min, 20°) over
Lymphoprep (Axis-Shield, Oslo, Norway) and washed
twice with sterile PBS (GIBCO, Paisley, UK) at 300 g
(5 min, 20°). Cells were resuspended in 10 ml RPMI-
1640 (Invitrogen, Paisley, UK) supplemented with 100 U/
ml of penicillin (GIBCO) and 100 lg/ml streptomycin
(GIBCO) and 20 mM HEPES buffer (Sigma-Aldrich,
Poole, UK) (RPMI), and plated at a density of approxi-
mately 5 9 106 cells/ml in 8 cm2 NunclonTM Surface tis-
sue culture dishes (Nunc, Roskilde, Denmark). After an
initial culture period of 2 hr at 37°, 5% CO2, the non-
adherent cells were discarded and 10 ml of fresh RPMI
supplemented with 10% fetal bovine serum (FBS)
(Sigma-Aldrich) (10% FBS/RPMI) was added to each
tissue culture dish. Cells were then cultured for 5 days at
37°, 5% CO2, with the addition of a further 10 ml fresh
10% FBS/RPMI after 24 hr. Adherent cells were scraped
on day 5 and re-plated at 105/well for cytokine analysis
and 106/well for RNA extraction in X-Vivo-15 medium
(Cambrex, Walkersville, MD). These primary MDM were
incubated overnight at 37°, 5% CO2 to adhere, and then
stimulated for 4 hr (transcriptomic studies) or 24 hr
(cytokine studies) with (100 : 1) heat-killed Escherichia
coli clone NCTC 10418 (HkEc).
Cytokine secretion assay
Supernatant was collected from HkEc-stimulated MDM
and an inflammatory cytokine assay was performed using
a custom-designed human multiplex assay (TNF-a, IFN-
c, IL-6, IL-8 and IL-10) (Meso Scale Discovery, Rockvilla,
MD) and read on a SECTOR Imager 6000 (Meso Scale
Discovery).
Release of TNF-a from THP-1 monocytic cells was
determined using the L929 bioassay, as described previ-
ously.9 Interleukin-6 (R&D Systems, Abingdon, UK) and
IL-10 (Peprotech, London, UK) release by THP-1 cells
were determined using ELISAs.
Cytokine release in culture supernatants was normal-
ized for the numbers of viable cells in each well,
ascertained with the MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyl tetrazolium bromide, tetrazolium salt) assay
(Boehringer Ingelheim, Berkshire, UK). Twenty microli-
tres of 25 ng/ml MTT was added to each well and incu-
bated for 4 hr at 37° in 5% CO2. Supernatants were
carefully discarded and 100 ll/well of lysis solution (90%
isopropanol, 05% SDS, 004 N HCl, and 10% H2O) was
added to each well for 1 hr at room temperature. The
absorbance was read at 570 nm using a microplate reader
(FLUOstar OMEGA; BMG Labtech, Buckinghamshire,
UK).
Whole genome microarray analysis
Total RNA was harvested from MDM using the RNeasy
Mini Kit with RNase-free DNase treatment (Qiagen, Hil-
den, Germany), in accordance with the manufacturer’s
instructions. Optical density readings were determined for
OD260/OD280 and OD260/OD230 using a NanoDrop
ND-1000 spectrophotometer (Thermo Fisher Scientific,
Hemel Hempstead, UK) to assess protein and solvent
contamination, respectively. RNA integrity was analysed
by assessing ribosomal RNA band 28S/18S ratios using
high-resolution electrophoresis on an Agilent Bioanalyser
(Agilent Technologies, Inc, Berkshire, UK) and attained
an integrity score of > 8. Total RNA (500 ng) was ampli-
fied using the Illumina TotalPrep-96 RNA Amplification
kit (Life Technologies Ltd, Paisley, UK), normalized to
150 ng/ll, and 750 ng was hybridized to Illumina
Human-WG6 v3.0 Expression BeadChips (Illumina,
Essex, UK) for 16 hr at 58°. Bead arrays were stained
with streptavidin-Cy3 (GE Healthcare, Amersham, UK)
and scanned using the Bead array reader and processed
with GENOMESTUDIO data analysis software (Illumina).
Data were smoothed with cubic spline normalization.
Microarray data analysis
Poor quality probes, as defined using the latest BioCon-
ductor21 Illumina annotation (ILLUMINAHUMANV4.db), were
excluded. Only probes that were detected at P < 001 in
at least 50% of the samples were retained. Batch effects
were corrected using ComBat normalization with disease
status as a covariate and efficacy of normalization was
verified by principal component analysis.22 Differential
gene expression analysis was conducted using LIMMA23
with adjustment for multiple testing by the method of
Benjamini and Hochberg.24
To detect subgroups of patients in whom expression
profiles for individual genes were different from the con-
trol population, we used the z-score outlier detection
(ZODET) method.25 This analysis aims to identify abnor-
mally expressed genes (‘outliers’) in individuals and sub-
groups compared with a cohort of healthy controls
(HC). Two adjustable thresholds were used to identify
potential probe outliers: (i) the significance level
(P-value) of the standardized deviation of the expression
levels from the test sample when compared with the
mean expression levels of the comparison group; this was
set at P < 0005; and (ii) the fold-change between the
expression level from the test sample and the mean of the
comparison group; this was set at 1 (on the log2 scale).
All of the transcriptomic data used in this study have
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been deposited in the Gene Expression Omnibus (GEO)
with accession no. GSE60083.
Statistical analysis of cytokine secretion data
Statistical significance of differences in cytokine secretion
data was assessed using Student’s t-test or paired t-test as
appropriate. A P-value < 005 was considered significant.
Pairwise correlation analysis of all possible cytokine
pairs was conducted with log2-transformed data sepa-
rately for CD and HC. The extent of correlation was
quantified by Pearson’s correlation coefficient.
Real-time quantitative PCR analysis
RNA (1 lg) was converted to cDNA using oligo d(T)
primers and reverse transcription using the Promega
reverse transcription kit (Qiagen). Real-time quantitative
PCR was performed using a SensiMix No Ref DNA kit
(Bioline reagents, London, UK), using peptidylprolyl
isomerase A as endogenous control. All samples and stan-
dards were run in triplicate. Primers for optineurin
(OPTN) were forward 50-TGCCTGACATAGACACGTTA
C-30, reverse 50-GGCAAAATATTTGAGTGAAACAA-30,
ADAMDEC1 forward 50-CGTGTAAACTGAAGCCTGG
A-30, reverse 50-TTCACAAGATTCCTGGGACAG-30, com-
mercially available primers for peptidylprolyl isomerase A
and GAPDH were used as endogenous controls (Human
Endogenous Control Gene Panel; Bioline). Relative expres-
sion was compared between groups using the DDCt method.
Sequencing of the OPTN genomic region
The reference sequence of the OPTN gene was obtained
from the University of California Santa Cruz (UCSC)
genome browser. Forward and reverse primers were
designed for specific amplification of OPTN exons, pro-
moter and downstream reactions (see Supporting infor-
mation, Table S1). PCR was carried out using Hotstar
Taq master mix (Qiagen GmbH) and 200 pmol of the
appropriate forward and reverse primers (Eurofins MWG
operon, Munich, Germany). PCR products were purified
using the QIAquick PCR purification kit (Qiagen
GmbH), in accordance with the manufacturer’s instruc-
tions. Sequencing of the fragments was conducted at the
Wolfson Institute for Biomedical Research, UCL by auto-
mated Sanger dideoxy sequencing reactions. Sequences
were searched for previously recognized variants in the
OPTN gene, as documented in the National Centre for
Biotechnology Information (NCBI) SNP database.
Western blotting
Western blotting was used to determine intracellular
OPTN levels. Cells were lysed in Laemmli sample buffer
(006 M Tris–HCl pH 68, 2% SDS, 10% glycerol, 5%
b2-mercaptoethanol (VWR, Leicestershire UK), 004%
[weight/volume (w/v)] bromophenol blue, Complete pro-
tease inhibitor cocktail tablet (Roche Diagnostics GmbH,
Mannheim, Germany), and phosphatase inhibitor cock-
tails 2 and 3 (Sigma-Aldrich). Proteins were separated by
SDS–PAGE and transferred onto Hybond P nitrocellulose
membrane (GE Healthcare, Buckinghamshire, UK) with a
semi-dry transfer system (Trans-Blot SD semi-dry transfer
cell; Bio-Rad, Hemel Hempstead, UK) in transfer buffer
[200 mM glycine, 01% SDS (w/v), 10% methanol (v/v),
25 mM Tris–HCl pH 88]. Membranes were incubated
overnight at 4° with primary antibodies directed against
OPTN (HPA003360; Sigma-Aldrich, 1 : 1000) or b-actin
(Sigma-Aldrich; 1 : 1000) and then with horseradish per-
oxidase-conjugated anti-rabbit IgG antibody (GE Health-
care, Amersham, UK, 1 : 2000) for 1 hr at room
temperature, and developed using the Enhanced Chemilu-
minescence method (ECL PLUS; GE Healthcare). Densi-
tometry analysis was performed using IMAGEJ software
(National Institutes of Health, Bethesda, MA), with band
densities normalized to b-actin.
Small interfering RNA knockdown in THP-1 cells
THP-1 cells (a human pro-monocytic cell line) were cul-
tured in RPMI-1640 medium (Invitrogen), supplemented
with 10% FBS (Sigma-Aldrich), 20 mM HEPES (Sigma-
Aldrich), 100 U/ml penicillin, 100 lg/ml streptomycin
(GIBCO) and 50 lM b2-mercaptoethanol (Invitrogen).
OPTN expression in THP-1 cells was depleted by trans-
fection of small interfering RNAs (siRNAs) targeted
against OPTN, using the Amaxa Cell line Nucleofector
kit V (Amaxa/Lonza, Basel, Switzerland). THP-1 cells
were harvested by centrifugation and washed with PBS.
Cells were resuspended in Nucleofector solution V, to
obtain a concentration of 106 cells/100 ll. For each trans-
fection, 100 ll of cell suspension was mixed with
60 pmol of appropriate siRNAs. Silencer pre-designed
and validated siRNA directed against OPTN was used to
deplete expression (ID # 4392420; Ambion, Austin, TX).
Non-targeting AccellTM siRNA was also used as a negative
control for off-target effects (catalogue no. D-001910- 01-
05, Dharmacon; Thermo Fisher Scientific). Transfection
was performed using an Amaxa Nucleofector (pro-
gramme U-01). Following transfection, cells were resus-
pended in RPMI-1640 medium (Invitrogen), supple
mented with 10% FBS (Sigma-Aldrich), 20 mM HEPES
(Sigma-Aldrich), 100 U/ml penicillin, 100 lg/ml strepto-
mycin (GIBCO) and 50 lM b2-mercaptoethanol (Invitro-
gen) and cultured at 37° in an atmosphere of 5% CO2.
Subsequent assays were performed 24 hr after transfec-
tion. For cytokine assays, 105 cells were resuspended in
100 ll medium and stimulated for 6 hr with 2 lg/ml
Pam3CSK4 (Alexis) or 20 HkEc/cell.
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Results
Pro-inflammatory cytokine secretion from MDM is
attenuated in CD
Given the important roles of TNF-a, IFN-c, IL-6, IL-8
and IL-10 in acute inflammation and the previous associ-
ation of these cytokines with CD, we determined their
secretion by macrophages over a 24-hr period of stimula-
tion with HkEc. The secretion of TNF-a (P = 00045)
and IFN-c (P = 00004) were significantly lower in the
CD cohort (n = 43) compared with the HC (n = 39)
(Fig. 1a,b) whereas equivalent amounts of IL-6, IL-8 and
IL-10 were released in the two groups (Fig. 1c–e).
Coordinated release of TNF-a and IFN-c is disrupted
in MDM from CD patients
Emerging evidence suggests that the post-translational
processing and secretion of cytokines proceeds via a tightly
regulated, complex process involving distinct, yet overlap-
ping pathways.17 The precise molecules and processes
involved are currently incompletely understood.18 To
identify whether there is any evidence of co-ordinated
cytokine secretion from MDM stimulated with HkEc, and
whether abnormalities in this process could account for
the defective release associated with CD, the correlation
between all pairs of cytokines was examined in HC and
CD separately. MDM from HC subjects demonstrated
strong positive correlations between levels of secreted
TNF-a and IFN-c in response to HkEc stimulation
(Fig. 1f) (r = 064, P = 95 9 106). There was also evi-
dence of a negative correlation between IL-10 and IL-6
(r = 039, P = 001). Interleukin-8 was not significantly
associated with any of the other cytokines tested. The
strong association between TNF-a and IFN-c was not evi-
dent in the MDM isolated from CD patients (Fig. 1g)
(r = 015, P = 033). The IL-6 association with TNF-a
(HC; r = 067, P = 28 9 106, CD; r = 047, P = 00016)
and IFN-c (HC; r = 060, P = 48 9 105, CD; r = 033,
P = 003) was preserved in MDM from CD patients but
the negative correlation with IL-10 (r = 002, P = 085)
was lost. These results suggest a breakdown in the coordi-
nated release of pro-inflammatory molecules in MDM
derived from patients with CD after HkEc stimulation. Of
note, the sample size in the CD group exceeded that of the
HC group, indicating that the failure to detect correlations
in CD was not due to insufficient power.
The transcription of cytokine genes in genes of HC and
CD MDMs was determined for both HC and CD before
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Figure 1. Inflammatory cytokine release from monocyte-derived macrophages (MDM) from patients with Crohn’s disease (CD; n = 43) and
healthy controls (HC; n = 39) after 24 hr heat-killed Escherichia coli clone NCTC 10418 (HkEc) stimulation. (a) Tumour necrosis factor (TNF),
(b) interferon-c (IFN-c), (c) interleukin-6 (IL-6), (d) IL-8, and (e) IL-10. Graphical representation of the regression analysis performed using a
Pearson’s correlation on the cytokine secretion from MDM after 24 hr HkEc stimulation in both the (f) HC (n = 39) and (g) CD (n = 43)
cohorts. Increased thickness of the interconnecting lines demonstrates the strength of the association (r value) and the colour denotes the direc-
tion (blue = positive and red = negative). *P < 005, **P < 001 and ***P < 0001.
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and after HkEc stimulation. In concordance with previous
findings, the transcription of all these genes was increased
by bacterial stimulation. No significant alteration in cyto-
kine gene induction for TNF-a, IFN-c, IL-6, IL-8 and
IL-10 in MDM derived from CD patients compared with
MDM from HC (Fig. 2), before or after HkEc stimula-
tion, indicating that the defective secretion of TNF-a and
IFN-c has another cause.
Outlier analysis of macrophage transcriptome
identifies candidate genes responsible for abnormal
cytokine secretion
To interrogate potential molecular lesions that might be
responsible for the impaired cytokine release in CD cells,
microarray analysis was performed on unstimulated
MDM. Direct comparisons of the transcriptome profiles
of CD (n = 58) and HC (n = 42) macrophages did not
reveal a difference between the two groups after correct-
ing for multiple testing (Table 2 and see Supporting
information, Table S2), which can be explained by the
highly heterogeneous nature of the disease. In addition,
the inability to separate macrophages from CD and HC
subjects by principle component analysis provides evi-
dence that the cellular phenotype arising from the cultur-
ing of the peripheral blood monocyte pool is similar in
the two groups (data not shown). We hypothesized that
subgroups of individuals within the CD population might
share common abnormalities in gene expression which
could influence cytokine secretion and searched for these
using ZODET.25 This method enables the identification
of gross abnormalities in gene expression in individual
patients’ transcriptomes, which can be combined to iden-
tify potential subpopulations. MDM expressed genes that
hybridized to 10 468 probes (detection P-value < 001 in
> 50% of cases) of which only 385 (37%) were identified
as expressed at significantly abnormal levels in one or
more of the 58 CD patients tested when compared with
the HC cohort (Fig. 3; see Supporting information Table
S3). Of these 385 probes, 166 were found to be under-
expressed and 204 over-expressed, with 15 probes being
identified as both over- and under-expressed (Fig. 3a).
The majority of probes identified were found in only one
individual, but 25 probes were expressed at significantly
abnormal levels in three or more CD subjects tested
(Fig. 3b; Table 3). The most frequently identified probe,
ILMN_2381899 corresponds to OPTN and was under-
expressed in seven individuals with CD (12% of the CD
patients tested) (Fig. 3c). OPTN has previously been asso-
ciated with vesicle trafficking, autophagy induction and
TNF receptor signalling.26–30 In addition to OPTN,
ILMN_2103107 [ADAM-like, decysin 1 (ADAMDEC1)],
ILMN_2160476 [chemokine (C-C Motif) Ligand 22
(CCL22)] and ILMN_1676256 (no annotated gene avail-
able) were identified as abnormally expressed in five of
the 61 CD patients screened. Quantitative PCR confirmed
the reduced expression of OPTN and ADAMDEC1 in the
patients identified as under-expressing these genes using
ZODET (Fig. 3d and data not shown).
Reduced OPTN expression associated with a specific
haplotype
Patients with CD who were identified as expressing low
OPTN levels (OPTNlow) were subjected to DNA sequenc-
ing across all 16 exons and approximately 2K bases
up- and downstream of the OPTN gene. No novel muta-
tions were detected in these individuals and all sequence
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Figure 2. Cytokine gene induction after heat-killed Escherichia coli clone NCTC 10418 (HkEc) stimulation in the healthy controls (HC; n = 14)
and Crohn’s disease (CD; n = 30) subjects. (a) Tumour necrosis factor (TNF), (b) interferon-c (IFN-c), (c) interleukin-6 (IL-6), (d) IL-8, (e) IL-
10 all demonstrated significant gene induction after HkEc stimulation. Cytokine mRNA levels were obtained from whole genome microarray
data. There was no difference in the level of gene induction between the HC and CD cohorts. #P < 0001.
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variations identified had been previously documented in
the 1000 Genomes Project (data not shown).31 Five of the
seven OPTNlow subjects were found to be homozygous
for the single nucleotide polymorphism (SNP)
rs12415716 (G/G, minor allele frequency 0183) (see Sup-
porting information, Fig. S1). The two other OPTNlow
patients were heterozygous (T/G) for this SNP. The geno-
type of the remaining CD and HC cohort was determined
and plotted against OPTN expression (Fig. 3e,f). The
rs12415716 SNP was found to be an expression quantita-
tive trait locus (eQTL) for OPTN. The presence of
rs12515716 minor allele G in the CD cohort (coeffi-
cent = 078, r2 = 074 and P-value = 20 9 1013) pro-
duced over twice the effect on OPTN gene expression
compared with the HC population (coefficient = 037,
r2 = 037 and P-value = 90 9 105). This difference is
driven predominately by the presence of the OPTNlow
outliers in the CD group. Using the 1000 Genomes data-
base and a linkage disequilibrium threshold of 08 (r2)
revealed that the SNP rs12515716 tags a region on chro-
mosome 10 spanning 13 200 041–13 222 655, which con-
tains the OPTN exons 7–16 (Fig. S1b–d). These results
demonstrate that the low OPTN level identified in the
seven CD subjects is partially due to the inheritance of a
haplotype tagged by the rs12415716 SNP.
Patients with low OPTN expression have reduced
intracellular protein levels and release diminished
amounts of TNF-a, IFN-c and IL-6 after HkEc
stimulation
The reduced expression of OPTN in seven CD patients
identified by microarray analysis was verified by quanti-
tative PCR (Fig. 3d). MDM were re-cultured from four
of these patients 6–12 months after original sampling
and they were found to consistently under-express
OPTN (data not shown). In addition to having low
transcription levels, the OPTNlow subjects were shown to
have reduced intracellular OPTN protein levels com-
pared with HC (Fig. 3g,h) and secreted reduced levels of
TNF-a, IFN-c and IL-6 compared with the HC cohort
after HkEc stimulation (Fig. 3i). In contrast, secreted
levels of IL-10 and IL-8 by MDM from CD and HC
were similar (Fig. 3i). In addition to OPTNlow CD sub-
jects the cytokine secretion profile of four of five indi-
viduals identified as low for ADAMDEC1 were also
tested (see Supporting information, Fig. S2a). These sub-
jects released reduced IFN-c and TNF-a but similar lev-
els of IL-6, IL-8 and IL-10 to the HC cohort. Further
work will be required to determine the role ADAMDEC1
plays in macrophage biology.
Table 2. Differential gene analysis of microarray data comparing resting monocyte-derived macrophages (MDM) from healthy controls (HC;
n = 42) and Crohn’s disease patients (CD; n = 58)
Probe Gene HC mean CD mean Fold change P-value ADJP
ILMN_1694671 ZFAND2A 817 789 028 983E-05 036
ILMN_1734184 PLBD2 843 861 018 00001458 036
ILMN_1808356 FAM3A 912 931 020 00002436 036
ILMN_1706498 DSE 900 881 019 0000373 036
ILMN_1811373 FAM20B 799 809 010 00004633 036
ILMN_1672662 SLC20A1 1035 1015 019 00004851 036
ILMN_1671054 HLA-A 1174 1141 033 00005167 036
ILMN_1730201 DTNA 717 740 023 00005298 036
ILMN_1773485 QKI 733 747 014 00005452 036
ILMN_1755134 HSPA4 659 668 009 00005542 036
ILMN_1741727 QPCT 1037 985 052 0000598 036
ILMN_1803483 KIAA2013 886 900 015 00006012 036
ILMN_1807981 SIGIRR 633 644 011 00006271 036
ILMN_1714433 MARCKSL1 728 695 033 00006424 036
ILMN_1796669 PSEN1 628 637 009 00006703 036
ILMN_1726967 TWSG1 693 702 008 00006712 036
ILMN_2160476 CCL22 938 872 066 00006893 036
ILMN_1651819 GALNT11 808 821 013 00007314 036
ILMN_2400500 CERS2 777 791 013 00008091 036
ILMN_2212763 ICAM3 724 695 029 00008527 036
There were no significant alterations in gene expression between HC and CD after correcting for multiple testing (ADJP, significance P < 005).
The top 20 probes ranked by uncorrected P-values are illustrated along with the mean expression levels in both HC and CD cohorts, fold change
between the HC and CD populations and the P-value after correction for multiple testing (ADJP). The complete analysis can be found in the
Supporting information, Table S2.
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Specific knock-down of OPTN results in diminished
TNF-a secretion after HkEc and Pam3CSK4 exposure
THP-1 mononuclear cells were transfected with siRNA
against OPTN and stimulated with HkEc. OPTN protein
levels were reduced by approximately 60% 24 hr after
siRNA transfection (Fig. 4a,b). OPTN knockdown did
not alter THP-1 viability any more than treatment with
mock and negative siRNA (data not shown). OPTN-defi-
cient THP-1 cells released significantly lower levels of
TNF-a and IL-6 but normal levels of IL-10 after HkEc
stimulation compared with mock-transfected cells
(Fig. 4c). OPTN-deficient THP-1 cells were also shown to
secrete reduced levels of TNF-a downstream of TLR2
activation (Fig. S2b). These results suggest that reduced
OPTN levels have a direct effect on cytokine secretion
and could contribute to the diminished levels identified
in a subgroup of CD patients.
Discussion
The evidence to support a link between abnormalities in
the innate immune response and CD is rapidly expand-
ing.6 Defective bacterial recognition through mutations in
NOD2 and anti-bacterial responses such as autophagy
activation have been shown to be abnormal in CD.6–9,13
In this study we provide further evidence of defective
secretion of pro-inflammatory cytokines by macrophages
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Figure 3. Gene expression analysis using microarray data from unstimulated monocyte-derived macrophage (MDM) from HC (n = 42, control
group) and CD (n = 58, test group) subjects. (a) MDM were found to express 10 468 probes (detection P-value < 001 in > 50% of cases) of
which < 35% were found to be expressed at abnormal levels (under- or over-expressed z-score P < 0005 and a fold change of > 1) in any of
the 58 CD patients tested. (b) The majority of the probes identified as abnormally expressed were unique to an individual. Only 11 and 14 probes
were over- or under-expressed, respectively in three or more CD subjects tested. (c) The most commonly identified probe (ILMN_2381899),
which corresponds to optineurin (OPTN), was under- expressed in seven patients out of the 58 tested. Each circle represents an individual’s
expression value for ILMN_2381899 overlaid with a box plot (mean plus 25th and 75th centile). Individuals that lie beneath the grey dotted line
were classified as an outlier. (d) Quantitative PCR was used to verify the under-expression of OPTN in the individuals (OPTNlow) identified as
outliers (HC n = 19, OPTNlow n = 7 and CD n = 13). (e) OPTN gene expression in macrophages from HC by single nucleotide polymorphism
(SNP) rs12415716 genotype. (f) OPTN gene expression in macrophages from CD by SNP rs12415716 genotype. (g) OPTN intracellular protein
levels were determined using MDM whole cell lysates and Western blotting. (h) Quantification of the levels of intracellular OPTN in OPTNlow
individuals (n = 4) compared with HC (n = 4). Individuals who demonstrated reduced OPTN gene expression were also found to have reduced
OPTN protein levels compared with HC. (i) MDM cytokine secretion profile from OPTNlow patients (n = 4) stimulated with HkEc for 24 hr
compared with the HC cohort (n = 43). OPTNlow individuals secreted reduced tumour necrosis factor (TNF), interferon-c (IFN-c) and interleu-
kin-6 (IL-6) but equivalent levels of IL-8 and IL-10 in comparison to the HC population. Students t-test, and ***P < 0001.
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from patients with CD. We have demonstrated a strong
association between secretion of TNF-a, IFN-c and IL-6
proteins from healthy control MDM in response to
E. coli, which is disrupted in CD. These results, combined
with previous findings, suggest that alterations in the
secretory pathways in the macrophages are responsible for
the diminished cytokine release and subsequent defective
acute inflammatory response observed in individuals with
CD.7–9,32
Cytokines and chemokines released from macrophages
play a key role in the regulation of the immune
response, acting as messengers that regulate the initializa-
tion and finally the resolution of the inflammatory
response to pathogens and acute injury. TLR and NLR
signalling pathways, which result in cytokine gene activa-
tion, have been extensively studied,10,11 but little infor-
mation is currently available on the mechanisms that
control the post-translational processing and release of
cytokines. To add further complexity, evidence suggests
that secretory processes may differ between cell types. In
this study we have used MDM and identified an associa-
tion between TNF-a, IFN-c and IL-6 at the level of
secretion after E. coli stimulation. A number of studies
have recently described an overlap in the secretory path-
ways for these three cytokines.17,18,33,34 Both TNF-a and
IFN-c were shown to share a secretory pathway involving
the recycling endosome-associated molecules vesicle asso-
ciated membrane protein 3 (VAMP3) and Rab11a in
natural killer cells. VAMP3 was also co-localized with
both TNF-a and IL-6 in the recycling endosome in acti-
vated RAW264.7 a mouse macrophages cell line. A single
nucleotide polymorphism (rs35675666) that tags a chro-
mosomal region that includes VAMP3 has been identi-
fied in patients with inflammatory bowel disease.4 An
alteration in the secretory process involving VAMP3 may
be partially responsible for the cytokine observations in
this study.
Interestingly, the secreted levels of IL-10 and IL-8
appear unrelated to the other cytokines measured in this
study, which may be due to the presence of alternative
secretory mechanisms. These alternative pathways seem to
be relatively unaffected in MDM from patients with CD.
The molecular machinery involved in these alternative
pathways is still unclear. Recently, IL-10 was shown to
possess two distinct exit strategies, one via the recycling
Table 3. Gene outlier analysis using microarray data from unstimu-
lated monocyte-derived macrophages (MDM) from healthy controls
(HC; n = 42) and Crohn’s disease patients (CD; n = 58)
Probe Gene Under-expressed Over-expressed
ILMN_2381899 OPTN* 7 0
ILMN_2103107 ADAMDEC1* 5 0
ILMN_2160476 CCL22 5 0
ILMN_1676256 TPSAB1 0 5
ILMN_1703538 AIF1 4 0
ILMN_1716909 ADAMDEC1 4 0
ILMN_1687757 AKR1C3 0 4
ILMN_2092118 FPR1 3 2
ILMN_1671568 ECHDC2 3 0
ILMN_1749403 TSPAN33 3 0
ILMN_1765332 TIMM10 3 0
ILMN_1782729 CLECL1 3 0
ILMN_1797875 ALOX5AP 3 0
ILMN_1815895 LOC649143 3 0
ILMN_2262288 EEF1G 3 0
ILMN_2341815 TFG 3 0
ILMN_1668039 GYPC 0 3
ILMN_1668134 GSTM1 0 3
ILMN_1670490 PDPN 0 3
ILMN_1710124 CMTM8 0 3
ILMN_1715401 MT1G 0 3
ILMN_1716218 RPS6KA2 0 3
ILMN_1752965 GREM1 0 3
ILMN_1810420 DYSF 0 3
ILMN_2169801 TPSAB1 0 3
All of the probes that were identified as reaching outlier significance
(under- or over-expressed z-score P < 0005 and a fold change of
> 1) in three or more CD subjects are shown. A full list of all out-
liers identified in this analysis can be found in the Supporting infor-
mation; Table S3.
*altered gene expression confirmed by qPCR.
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Figure 4. Knockdown of optineurin (OPTN) by small interfering
RNA (siRNA) results in reduced cytokine secretion after bacterial
stimulation. (a) Western blot analysis of OPTN levels in THP-1
cells 24 hr after siRNA treatment. (b) Quantification of the OPTN
protein level 24 hr after siRNA treatment (n = 6). (c) Changes in
cytokine secretion resulting from reduced OPTN expression after
heat-killed Escherichia coli clone NCTC 10418 (HkEc) exposure was
determined. ELISAs were used to calculate the effects on tumour
necrosis factor (TNF), interleukin-6 (IL6) and IL-10 secretion
after OPTN knockdown. Paired students t-test *P < 005 and
**P < 001.
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endosomes and a second post-Golgi route that also trans-
ports apolipoprotein E.35 Pathways associated with IL-8
release from macrophages remain less well defined. One
study using HL60 human promyelocytic leukaemia cells
reported a secretory pathway for IL-8 that involved an
autophagy-related structure termed the TOR-autophagy
spatial coupling compartment (TASCC).36 It is unclear if
the TASCC structure is present in the MDM used in our
study or if this is the only secretory pathway used by IL-
8. Further studies are needed to unravel the complexities
associated with macrophage cytokine secretion.
To identify the molecular basis of defective cytokine
trafficking we have applied an outlier gene analysis strat-
egy, which has previously been successfully used in iden-
tifying heterogeneous molecular aberrations in certain
cancers.37 This approach yielded a relatively small num-
ber of genes that were expressed at significantly altered
levels in the MDM from subgroups of CD patients. The
most frequently under-expressed gene was the multifunc-
tional adapter protein OPTN. Functional studies on
OPTN revealed a potential role in cytokine secretion
from macrophages after bacterial and TLR activation.
OPTN has been previously implicated in vesicular traf-
ficking from the Golgi to the plasma membrane.28 The
precise role attributed to OPTN seems to be cell-type-
specific and studies on its role in human macrophages
have not been reported. One study using mouse bone-
marrow-derived macrophages identified a role for OPTN
in TANK-binding kinase 1 (TBK1) activation and IFN-b
production.26 A recent study has demonstrated that
mutations in the ubiquitin binding site of OPTN
(Optn470T) in mice results in the alteration of IFN-b
gene induction through reduced IFN response factor 3
activation, but did not affect the secretion of TNF-a after
lipopolysaccharide stimulation.27 These findings suggest
that either the ubiquitin binding site in OPTN is not
required for TNF-a secretion or there is a fundamental
difference between mouse and human macrophages. The
other potential explanation is a difference in stimuli used
between our studies and the ones reported. The use of
whole bacteria and the TLR2 ligand Pam3CSK4 may
result in a different requirement for OPTN in the down-
stream processes.
Heterozygous mutations in OPTN have previously been
linked to glaucoma and amyotrophic lateral sclerosis,
although sequencing all exons of the OPTN gene in all
seven patients identified as outliers revealed no such
mutations, and no patients had any clinical features of
glaucoma or neurodegenerative disease (data not
shown).38 We were able to identify a haplotype that dem-
onstrated a strong correlation with OPTN expression.
The haplotype was tagged by the SNP rs12415716 which
has a reported minor allele frequency of 018. rs1751262,
which is in perfect linkage disequilibrium with
rs12415716, has been shown to effect OPTN expression
in fibroblasts.39 The effect on OPTN expression in indi-
viduals who are homozygous for the minor haplotype
seems to be more pronounced in the CD patients than in
HC. The reason for the difference in effect between indi-
viduals is still unclear, but could involve epistasis,
whereby distant polymorphisms directly influence the
effects of other polymorphisms on gene expression.40 A
recent study by Hemani et al. described this phenomenon
in peripheral blood cells and identified 129 genes that
were influenced by three to 14 SNPs located on multiple
chromosomes. This study highlights the complexity of
gene expression and the potential impact that epistasis
could have on human traits and diseases. We note that
there is no association between this eQTL SNP and CD
risk, as assessed by genome-wide association studies. Fur-
ther studies will be required to ascertain the precise role
played by OPTN in macrophage biology and cytokine
secretion, and the reason for defective OPTN expression
in these patients. To confirm an association between the
under-expression of OPTN (and the additional genes
reported) and susceptibility to CD, further replication
cohorts will be required.
The studies presented here build on the mounting evi-
dence of a defective innate immune response in individu-
als who develop CD. Defective cytokine secretion
identified in patients with CD is restricted to a subset of
cytokines that seem to share overlapping intracellular
trafficking pathways. Alterations in the expression levels
or mutations in the proteins involved in the complex
trafficking pathways could result in the reduced cytokine
secretion observed. The inability to release sufficient levels
of potent pro-inflammatory mediators will potentially
alter the ensuing inflammatory response. The implemen-
tation of a gene outlier analysis has identified a number
of potential genes that could have a role in cytokine traf-
ficking and processing in macrophages.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Haplotype associated with the reduced opti-
neurin (OPTN) mRNA expression identified in patients
with Crohn’s disease.
Figure S2. Monocyte-derived macrophage (MDM)
cytokine secretion profile from ADAMDEC1low patients
(n = 4) stimulated with heat-killed Escherichia coli clone
NCTC 10418 (HkEc) for 24 hr compared to the healthy
control (HC) cohort (n = 39).
Table S1. List of primers used to sequence the optineu-
rin (OPTN) gene region.
Table S2. Differential gene analysis comparing resting
monocyte-derived macrophages (MDM) from healthy
controls (HC; n = 42) and patients with Crohns’s disease
(CD (n = 58).
Table S3. List of probes identified as under- or over-
expressed in one or more Crohn’s disease (CD) patient
(n = 61) compared with the healthy control (HC) cohort
(n = 43).
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